Blog

Focused Ultrasound Featured in NIH’s Clinical Neuroscience Grand Rounds

Published:
Key Points Focused ultrasound was the topic of the November 12 Clinical Neuroscience Grand Rounds hosted by the National Institutes of Health (NIH).  NIH Clinical Center Senior Scientist, Scott Burks, PhD, and Suzanne LeBlang, MD, the Foundation’s director of clinical relationships presented the latest research.  The National Institute of Neurological Disorders and Stroke (NINDS), which is part of the National Institutes of Health (NIH), holds Clinical Neuroscience Grand Rounds each week. The format for the lecture series is a 30-minute case study presentation followed by a 60-minute main lecture. Attendees may join in person on the NIH campus (Building 10, Lipsett Amphitheatre), which includes a pre-lecture networking coffee session, or join virtually via Zoom.  The November 12 Grand Rounds featured focused ultrasound research as the main topic. Suzanne LeBlang, MD, the Foundation’s Director of Clinical Relationships, led off the morning by presenting the state of the field for focused ultrasound and Alzheimer’s disease. Her talk provided an overview of research that has been done using focused ultrasound for either neuromodulation or blood-brain barrier opening (BBBO). Focused ultrasound BBBO allows the body’s immune system – either with or without enhanced drug delivery – to reach the brain and decrease the amount of amyloid.  As a case example, Dr. LeBlang highlighted a patient reported in the 2024 New England Journal of Medicine article by Rezai, et al. where the side of the brain that received focused ultrasound after infusion of anti-amyloid antibodies had a significant decrease in amyloid compared with the side that did not receive the focused ultrasound sonications. In addition, she presented research from another mechanism of action, focused ultrasound neuromodulation (without BBBO), that resulted in decreased amyloid and cognitive improvement across various preclinical and clinical studies.  Scott Burks, PhD, a senior scientist at the NIH Clinical Center, then presented his lecture titled, “The Neuroinflammatory Consequences of Blood-Brain Barrier Opening.” His talk shared the latest translational research investigating the mechanistic biology of ultrasound-tissue interactions. He also described his research on the sterile inflammatory response in the brain after focused ultrasound and how immune cells react to BBBO. His work centers around designing novel clinical applications for focused ultrasound.  Both presentations are now available on the Foundation’s YouTube Channel.  “This program was an exciting opportunity to share the latest clinical research with focused ultrasound and Alzheimer’s disease. Much of the translational work has been made possible by the seminal research performed by Dr. Burks and his colleagues. The entire program generated a lot of interest and great questions,” said Dr. LeBlang.  For More Information on Focused Ultrasound for Alzheimer’s Disease In her presentation, Dr. LeBlang shared a recent review paper by Nadiyeh Rouhi et al. titled “A comprehensive review of advanced focused ultrasound (FUS) microbubbles-mediated treatment of Alzheimer’s disease.”  Read More About NINDS’ Clinical Neurosciences Grand Rounds  Watch the Recording 
Read More ...

Neck Dystonia: Focused Ultrasound Clinical Trial Results

Published:
Key Points Data from a 10-patient pilot clinical trial using focused ultrasound to treat cervical dystonia were recently published.  Cervical dystonia is a rare neurological disorder that causes uncontrollable neck muscle contractions.  Focused Ultrasound Pallidothalamic Tractotomy in Cervical Dystonia: A Pilot Study  Final data from a pilot clinical trial in Tokyo, Japan, were recently published in the journal Movement Disorders. Shiro Horisawa, MD, a neurosurgeon at Tokyo Women’s Medical University, led the 10-patient trial (Japan Registry of Clinical Trials Number 032210506). The study evaluated the safety and initial effectiveness of using Insightec’s Exablate Neuro focused ultrasound device to create a pallidothalamic tractotomy, or brain lesion, in patients with a rare condition of the neck called cervical dystonia.  People with cervical dystonia can experience uncontrollable neck muscle contractions, and the condition is also known as spasmodic torticollis. It is rare neurological disorder that is caused by faulty neurons in the brain. According to the National Organization for Rare Disorders, “In some cases, these abnormal contractions may be sustained or continuous; in others, they may be present as spasms that can resemble tremor. The severity of cervical dystonia can vary, but the disorder can cause significant pain and discomfort as well as difficulty due to the abnormal postures. It can affect quality of life and activities of daily living including employment.”  Six men and four women between the ages of 41 and 61 years were enrolled in the study. They were assessed with the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) at baseline and again six months after undergoing the focused ultrasound procedure. The TWSTRS score improved 43.4% from baseline to six months after treatment, and this improvement was significant (P < 0.001). Another significant improvement was measured in the Burke-Fahn-Marsden Dystonia Rating Scale, which improved by 38.2% (P < 0.001) from baseline. The Beck Depression Inventory, Beck Anxiety Inventory, and Apathy Evaluating Scale all improved as well. Some adverse effects were found, including reduced hand dexterity in three participants and weight gain in two of them.  The authors concluded that focused ultrasound pallidothalamic tractotomy may be an effective treatment option for patients with cervical dystonia. The publication also mentions that “Unilateral surgical treatment may be insufficient as a treatment for cervical dystonia,” noting that the treatment may need to be done bilaterally instead of only on one side, as is typically done with successful deep brain stimulation treatments.   “This is the first clinical trial of focused ultrasound surgery for cervical dystonia,” said Dr. Horisawa. “The participants showed significant improvements in their TWSTRS scores; however, we did find a wide range of individual responses. My next step is to investigate how focused ultrasound can address cases where the improvement from this treatment was insufficient. This includes exploring the potential for bilateral treatment and identifying the optimal parameters for selecting suitable patients. I am committed to continuing my research to solve these challenges and to improve the lives of dystonia patients worldwide.”  “The treatment of patients with Parkinson’s disease also produced some improvement in their dystonia, which prompted the expansion of this work to treat patients with other types of dystonia,” said Tim Meakem, MD, a managing director of the Foundation and co-director of the Research and Education Team. “We are thankful for Dr. Horisawa’s research and look forward to further refinements and expansions of this innovative technology.”  The Foundation funded this clinical trial, the first in the world use of focused ultrasound for treating cervical dystonia.  See Movement Disorders  Related Stories  Clinical Trial of Focused Ultrasound for Cervical Dystonia Begins June 2022
Read More ...

New Textbook Describes All Aspects of Focused Ultrasound

Published:
Key Points Distinguished editors from the Institute of Cancer Research and the University of Oxford recently published a comprehensive new focused ultrasound textbook.  The book describes the various mechanisms of focused ultrasound, along with the bioeffects and clinical applications of each mechanism.  Image-Guided Focused Ultrasound Therapy: Physics and Clinical Applications, 1st Edition Edited By Feng Wu, MD, PhD, Gail ter Haar, DSc, and Ian Rivens, PhD  A comprehensive new focused ultrasound textbook was published this year. The editors – focused ultrasound experts from the Institute for Cancer Research (ICR) and the University of Oxford – invited world experts to write each chapter with the goal of presenting the latest clinical outcomes of using focused ultrasound for the treatment of benign and malignant diseases.  “This book is a great primer for anyone entering the field of focused ultrasound,” said Emily White, MD, the Foundation’s managing director for operations and FUS Partners. “It would be appropriate for grad students, post-docs, and for new hires at focused ultrasound manufacturers, sales teams, and distributors. It is a good reference to have on anyone’s bookcase!”  The book describes the fundamental physics behind the various mechanisms of focused ultrasound, along with the bioeffects and clinical applications of each mechanism. Ablation, hyperthermia, drug delivery, sonoporation, histotripsy, cancer immunotherapy, and the interaction between microbubbles and ultrasound are all included.  The specific use of focused ultrasound therapy for more than ten indications is also described. These chapters cover the current clinical guidelines for indications, contraindications, patient selection, the treatment procedure, follow-up, and the expected imaging changes after treatment.  Chapters/Table of Contents  Image-Guided Focused Ultrasound Therapy: Past, Current and Future.  Physical Principles of Focused Ultrasound Therapy.  Mechanisms for Induction of Bio-Effects of Focused Ultrasound in Tissue.  Image-Guided Focused Ultrasound Therapy: Physics and Clinical Applications.  Calibration and quality assurance for high intensity focused ultrasound fields.  Numerical Modelling for Simulation and Planning of Focused Ultrasound Treatments.  Ultrasound Monitoring Techniques for Focused Ultrasound Therapy.  Extracorporeal Ultrasound-guided HIFU Devices — Clinical Application, Treatment Planning and B-mode Ultrasound for Real-time Monitoring and Controlling of Treatment.  Imaging Assessments of Tumour Response and Treatment Outcome after High-intensity Focused Ultrasound Ablation.  Focused Ultrasound Treatment of the Prostate: Devices and Clinical Results.  Ultrasound-Guided Focused Ultrasound Ablation for Uterine Fibroids.  Clinical Application of Ultrasound-Guided Focused Ultrasound Ablation for Liver Tumours.  Clinical Application of Ultrasound-Guided Focused Ultrasound Ablation for Kidney Tumours.  Clinical Application of Ultrasound-Guided Focused Ultrasound Ablation for Pancreatic Cancer.  Clinical Application of Ultrasound-Guided Focused Ultrasound Ablation for Breast Tumours.  Clinical Application of Ultrasound-guided High Intensity Focused Ultrasound Treatment for Primary Bone Malignancies and Soft Tissue Sarcomas.  Clinical Extracorporeal MR-Guided Focused Ultrasound Systems: Treatment Planning, Therapy Delivery, and Online Monitoring via Thermometry and Thermal Dose Mapping.  Clinical Application of MR-Guided Focused Ultrasound Ablation for Uterine Fibroids.  Clinical Application of MR-Guided Focused Ultrasound Ablation for Tumours in the Breast.  Clinical Application of MR-Guided Focused Ultrasound Ablation for Bone Metastasis.  Clinical Application of MR-Guided Focused Ultrasound Therapy in the Brain.  Sonoporation: Concept, Mechanisms and Application to Cancer Treatment.  Nano/Microbubble-assisted Ultrasound for Drug Delivery in Cancer.  Anaesthesia, Ventilation and immobilisation Strategies for Focused Ultrasound Therapy (with special reference to high frequency ventilation).  Triggered Temperature-Sensitive Liposome Release by Focused Ultrasound for Localised Drug Delivery.  Transcranial Ultrasound-Mediated Blood-Brain Barrier Disruption for Targeted Drug Delivery.  Histotripsy: Focused Ultrasound Therapy by Mechanical Tissue Fractionation.  Focused Ultrasound Ablation Enhancement of Specific Anti-Tumour Immunity.  Focused Ultrasound Therapy for Treatment of Pain.  Image-Guided Focused Ultrasound Therapy: Physics and Clinical Applications is part of a series on Medical Physics and Biomedical Engineering.  Order the Book from Routledge Publishing 
Read More ...
Watch Now: Webinar on Immunotherapies for Breast Cancer Meeting Report: American Association of Neurological Surgeons (AANS) 2024 Meeting Report: The International Society for Magnetic Resonance in Medicine (ISMRM) and the International Society for MR Radiographers and Technologists (ISMRT) 2024 Joint Meeting Histotripsy for Liver Tumors: Clinical Trial Results Published Focused Ultrasound for Psychiatric Disorders: Workshop White Paper Now Available